Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AZD-0292 by AstraZeneca for Bronchiectasis: Likelihood of Approval
AZD-0292 is under clinical development by AstraZeneca and currently in Phase I for Bronchiectasis. According to GlobalData, Phase I drugs...